SCHEMBL14149593

SCHEMBL14149593

NS(=O)(=O)c1cc(Br)c2c(c1)CCN2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 13/20 0.46
CA1 P00915 12/20 0.46
CA9 Q16790 9/20 0.46
CA3 P07451 1/20 0.46
ADRA2A P08913 1/20 0.45
PNMT P11086 1/20 0.45
ADRA2B P18089 1/20 0.45
ADRA2C P18825 1/20 0.45
CA12 O43570 4/20 0.44
CA7 P43166 6/20 0.40
CA14 Q9ULX7 6/20 0.40
CA4 P22748 1/20 0.38
CA6 P23280 1/20 0.38
CA5A P35218 1/20 0.38
CA5B Q9Y2D0 1/20 0.38
PDPK1 O15530 1/20 0.34
PHLPP1 O60346 1/20 0.34
AKT1 P31749 1/20 0.34
ILK Q13418 1/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14058835 0.79 ADRA2A (0.39) CA2CA1CA9CA3ADRA2A
SCHEMBL31647361 0.77 SIRT2 (0.40) PNMTALDH1A1MAPT
SCHEMBL14058834 0.77 SMN1; SMN2 (0.56) PNMTALDH1A1
SCHEMBL31646603 0.77 GFER (0.32) ADRA2APNMTADRA2BADRA2C
SCHEMBL30288495 0.76 CA2 (0.51) CA2CA1CA9CA3ADRA2A
SCHEMBL4870530 0.74 PARP10 (0.43) PNMTALDH1A1MAPTPARP10PARP11
SCHEMBL7218785 0.71 ACHE (0.48) CA2CA1CA9CA7CA14
Hydrochloric Acid SCHEMBL4866638 0.70 ACHE (0.47) CA2CA1CA9CA7CA14
SCHEMBL29710882 0.70 CA1 (0.81) CA2CA1CA9ADRA2APNMT
SCHEMBL3238863 0.70 CA1 (0.81) CA2CA1CA9ADRA2APNMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2714681-B1 SUBSTITUTED SULFONAMIDES USEFUL AS ANTIAPOPTOTIC BCL INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2015-06-24 EP disclosed
WO-2012162365-A1 SUBSTITUTED SULFONAMIDES USEFUL AS ANTIAPOPTOTIC BCL INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-11-29 WO disclosed